Journal of minimally invasive gynecology
-
J Minim Invasive Gynecol · Nov 2014
Sydney contained in bag morcellation for laparoscopic myomectomy.
To demonstrate a new technique of contained in bag morcellation of a myoma after laparoscopic myomectomy. ⋯ This technique may enable a minimally invasive approach to myomectomy to continue as a viable option in the era since the warning by the US Food and Drug Administration.
-
J Minim Invasive Gynecol · Sep 2014
Randomized Controlled Trial Comparative StudyComparison of nonsteroidal anti-inflammatory drugs and misoprostol for pain relief during and after hysterosalpingography: prospective, randomized, controlled trial.
To assess whether vaginal misoprostol or oral nonsteroidal anti-inflammatory drugs (NSAIDs) reduce pain during and 30 minutes after hysterosalpingography (HSG). ⋯ There is no benefit in terms of pain reduction with the use of misoprostol during HSG or at 30 minutes after the procedure. However, NSAIDs are associated with pain relief during the HSG procedure.
-
To measure the safety culture in the robotics surgery operating room before and after implementation of the Robotic Operating Room Computerized Checklist (RORCC). ⋯ Quality of communication and collaboration in the gynecology robotics operating room is high between most positions; however, safety attitude responses are low overall. No differences after RORCC implementation and low response rates may highlight lack of staff support.
-
J Minim Invasive Gynecol · Sep 2014
Multicenter StudyThree-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas.
To analyze the clinical success of radiofrequency volumetric thermal ablation (RFVTA) at 3-year follow-up in terms of subject responses to validated questionnaires and surgical repeat intervention to treat myomas. ⋯ RFVTA of uterine myomas resulted in sustained relief from myoma symptoms and continued improvement in health-related quality of life through 36 months after ablation. The low repeat intervention data through 36 months is a positive outcome for patient well-being.